Aegon

AEG

Market cap $12.4B

Investors interested in Insurance - Multi line stocks are likely familiar with Aegon NV (AEG) and Prudential (PUK). But which of these two stocks offers value investors a better bang for their buck right now?

Here is how Aegon NV (AEG) and Bank of America (BAC) have performed compared to their sector so far this year.

Aegon Ltd. ( AEG ) Q3 2025 Sales Call November 13, 2025 3:00 AM EST Company Participants Yves Cormier - Head of Investor Relations E. Friese - CEO, Chairman of Management Board & Executive Director Duncan Russell - CFO & Member of Management Board Conference Call Participants David Barma - BofA Securities, Research Division Iain Pearce - BNP Paribas, Research Division Nasib Ahmed - UBS Investment Bank, Research Division Jason Kalamboussis - ING Groep N.V.

Schiphol, November 13, 2025 - Please click here to access all 3Q 2025 trading update related documents.

Schiphol, November 3, 2025 - Aegon announces today that David Herzog, who was appointed as a member of the Board of Directors (BoD) at Aegon's 2025 Annual General Meeting of shareholders (AGM), will succeed William Connelly as Chairman of the BoD as of November 13, 2025. In line with previous announcements, Mr Connelly will retire as Chairman and member of the BoD on the same date.

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.

Aegon (AEG) has transformed into a consistent performer, delivering strong results and a 6% dividend yield, with management meeting financial targets. AEG is relocating its domicile to the US, aiming to close the valuation gap with North American peers and potentially pursue M&A-driven growth. Management's track record and relationships suggest a possible merger or acquisition with Voya (VOYA), leveraging synergies and shared history.

Here is how Aegon NV (AEG) and American Healthcare REIT (AHR) have performed compared to their sector so far this year.

Aegon remains a Buy following strong H1 results, a €400 million share buyback, and the strategic sale of a.s.r. shares. The company's divestment of 12.5 million a.s.r. shares enhances financial flexibility, supports deleveraging, and creates room for shareholder returns. Potential US re-domicile and NYSE primary listing could drive a re-rating and higher liquidity for the company, with further details expected at the December Capital Market Day.

GFI, GMAB and AEG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 3, 2025.